[An analysis of the causes for the occurrence of Down's syndrome and the current approaches to its prevention at the stage of mass prenatal ultrasonic and immunobiochemical screening of pregnant women]
- PMID: 8721852
[An analysis of the causes for the occurrence of Down's syndrome and the current approaches to its prevention at the stage of mass prenatal ultrasonic and immunobiochemical screening of pregnant women]
Abstract
Problems of prenatal complex diagnosis of Down's syndrome are considered. The levels of alpha-fetoprotein in blood serum of pregnant women should be studied in the optimum terms (17-19 weeks of pregnancy). The assessment of several immuno-biochemical markers is most important for diagnosis.
Similar articles
-
Prenatal screening for Down's syndrome with use of maternal serum markers.N Engl J Med. 1992 Aug 27;327(9):588-93. doi: 10.1056/NEJM199208273270902. N Engl J Med. 1992. PMID: 1379344
-
Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.J Matern Fetal Med. 1996 Mar-Apr;5(2):70-3. doi: 10.1002/(SICI)1520-6661(199603/04)5:2<70::AID-MFM4>3.0.CO;2-N. J Matern Fetal Med. 1996. PMID: 8796771
-
Prenatal biochemical screening for Down's syndrome and neural tube defects.Curr Opin Obstet Gynecol. 1992 Apr;4(2):302-7. Curr Opin Obstet Gynecol. 1992. PMID: 1373963 Review.
-
[Screening by maternal serum markers for Down's syndrome].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Apr;25(2):156-9. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003. PMID: 12905710 Chinese.
-
Neural tube defects/alpha-fetoprotein/Down's syndrome screening.Curr Opin Obstet Gynecol. 1997 Apr;9(2):113-20. Curr Opin Obstet Gynecol. 1997. PMID: 9204233 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical